lutetium has been researched along with Multiple Myeloma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baron, F; Beguin, Y; Caers, J; D'Huyvetter, M; Devoogdt, N; Dumoulin, M; Duray, E; Krasniqi, A; Lauwers, Y; Lejeune, M; Zhao, YJ | 1 |
| Demirkol, MO; Ferhanoğlu, B; Özkan, A; Uçar, B; Wester, HJ | 1 |
2 other study(ies) available for lutetium and Multiple Myeloma
| Article | Year |
|---|---|
A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma.
Topics: ADP-ribosyl Cyclase 1; Animals; Camelidae; Cell Line, Tumor; Humans; Lutetium; Mice; Multiple Myeloma; Radioisotopes; Single Photon Emission Computed Tomography Computed Tomography; Single-Domain Antibodies; Tissue Distribution | 2021 |
Extramedullary Relapsed Multiple Myeloma Treatment With 177Lu-Labeled CXCR4 Endoradiotherapy and Dosimetric Results.
Topics: Female; Humans; Isotope Labeling; Lutetium; Male; Middle Aged; Multiple Myeloma; Radioisotopes; Radiometry; Receptors, CXCR4; Recurrence | 2021 |